Early diagnosis of Alzheimer's disease: update on combining genetic and brain-imaging measures

Diagnosis of Alzheimer's disease is often missed or delayed in clinical practice; thus, methods to improve early detection would provide opportunities for early intervention, symptomatic treatment, and improved patient function. Emerging data suggest that the disease process begins years before clinical diagnostic confirmation. This paper reviews current research focusing on methods for more specific and sensitive early detection using measures of genetic risk for Alzheimer's disease and functional brain imaging. This approach aims to identify patients in a presymptomatic stage for early treatment to delay progressive cognitive decline and disease onset.

[1]  R. Abbott,et al.  Frequency and characteristics of silent dementia among elderly Japanese-American men. The Honolulu-Asia Aging Study. , 1997, JAMA.

[2]  E. Corder,et al.  No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. , 1997, Archives of neurology.

[3]  D. Galton,et al.  Apolipoprotein E genotyping in Alzheimer's disease. , 1996, Lancet.

[4]  J. Morris,et al.  Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease , 1999, Annals of neurology.

[5]  N. Saunders,et al.  Recognition of dementia in general practice: comparison of general practitioners' opinions with assessments using the mini-mental state examination and the Blessed dementia rating scale. , 1988, Family practice.

[6]  J. Haines,et al.  Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. , 1997, JAMA.

[7]  HERMAN BUSCHKE,et al.  Evaluating storage, retention, and retrieval in disordered memory and learning , 1974, Neurology.

[8]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[9]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[10]  S H Ferris,et al.  Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. , 1997, JAMA.

[11]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[12]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[13]  J. Haines,et al.  No association or linkage between an intronic polymorphism of presenilin‐1 and sporadic or late‐onset familial Alzheimer disease , 1997, Genetic epidemiology.

[14]  J. Haines,et al.  D2 dopamine receptor A1 allele in Alzheimer disease and aging. , 1997, Archives of neurology.

[15]  G W Small.  Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease. , 1996, The Journal of clinical psychiatry.

[16]  J C Mazziotta,et al.  Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. , 1995, JAMA.

[17]  J. Haines,et al.  Complete Genomic Screen in Late-Onset Familial Alzheimer’s Disease , 1998, Neurobiology of Aging.

[18]  R. Ernst,et al.  The US economic and social costs of Alzheimer's disease revisited. , 1994, American journal of public health.

[19]  D R Wekstein,et al.  Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. , 1996, JAMA.

[20]  S. Thibodeau,et al.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.

[21]  R. Powers,et al.  Knowledge About Alzheimer Disease Among Primary Care Physicians, Psychologists, Nurses, and Social Workers , 1997, Alzheimer disease and associated disorders.

[22]  H. Kraemer,et al.  The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults. , 1998, Journal of the American Geriatrics Society.